Multivariate contaminated normal linear mixed models applied to Alzheimer's disease study with censored and missing

Tsung-I Lin1,2, Wan-Lun Wang3

  • 1Institute of Statistics, National Chung Hsing University, Taichung, Taiwan.

Insights

This study introduces a new statistical model to effectively analyze complex longitudinal clinical data, even with outliers, missing, or censored values. The multivariate contaminated normal linear mixed model (MCNLMM-CM) improves data analysis accuracy.

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Clinical Research Methodology

Background:

  • Multivariate linear mixed models are standard for repeated measures but struggle with outliers and missing data.
  • Existing methods may not adequately handle complex clinical datasets with censored and intermittent missing responses.
  • Robust statistical modeling is crucial for accurate analysis of patient data in clinical studies.

Purpose of the Study:

  • To develop a robust statistical model for jointly analyzing multiple, complex, repeated clinical measures.
  • To extend the capabilities of multivariate linear mixed models by incorporating a multivariate contaminated normal distribution.
  • To effectively handle outliers, censored data, and missing responses in longitudinal clinical studies.

Main Methods:

  • The proposed multivariate contaminated normal linear mixed model with censored and missing responses (MCNLMM-CM) was developed.
  • An expectation conditional maximization (ECM) algorithm was employed for parameter estimation with missing at random responses.
  • Techniques for standard error approximation, data recovery, imputation, and outlier identification were provided.

Main Results:

  • A simulation study demonstrated the superior finite-sample performance of the MCNLMM-CM compared to existing models.
  • The model effectively handles minor outliers, censored measurements, and intermittent missing responses.
  • Parameter estimators showed robust properties in the simulation.

Conclusions:

  • The MCNLMM-CM offers a robust and effective approach for analyzing complex longitudinal clinical data.
  • The methodology is well-suited for datasets with data quality issues like outliers and missingness.
  • The model's application to Alzheimer's disease neuroimaging data highlights its practical utility.

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
56
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
26
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
85
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
131
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437